Hospital Acquired Infections (HAI) are a leading cause of death and/or severe long-term illness in premature babies. Preterm infants acquire HAI’s during prolonged residence in intensive care units (ICU), often transferred from medical equipment such as their incubator or water-based aerosols from washing/cleaning. This project will develop new sustainable materials of construction for ICU equipment, that will both resist microbial colonisation (reducing infections and improving outcomes) and reduce the healthcare sectors dependence on petrochemicals (reducing carbon-footprint).
This is a multidisciplinary project lead by Nottingham’s Centre for Additive Manufacturing (Engineering), comprising ~100 researchers hosted in state-of-the-art facilities. The team also includes a neonatologist (School of Medicine), a biomaterials scientist (Faculty of Science) and our industrial collaborator (Angel Guard Ltd).
The student will develop the new materials and test them in-use, working closely with Angel Guard. There will be opportunities to train at the Harwell Research Complex learning cutting edge analytical skills and spend time at research-active neonatal ICU to better understand the clinical needs. This PhD will suit a highly ambitious chemistry/engineering graduate, wishing to undertake a truly translational clinical/industry linked project. The student will be well placed to secure follow-on funding for clinical trials or on-going development/commercialisation.